Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by LiliPeptide.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 148 | 99.57% | Sep 8, 2026 |
| Tirzepatide | 41 | 99.78% | Aug 25, 2026 |
| GHK-Cu | 26 | 99.81% | Aug 20, 2026 |
| BPC-157 | 23 | 99.53% | Sep 8, 2026 |
| Tesamorelin | 23 | 96.65% | Aug 25, 2026 |
| MOTS-c | 9 | 99.1% | Aug 2, 2026 |
| Ipamorelin | 9 | 98.94% | May 31, 2026 |
| TB-500 | 9 | 97.16% | Jun 23, 2026 |
| PT-141 | 9 | 99.31% | May 31, 2026 |
| Melanotan II | 5 | 99.24% | Sep 3, 2026 |
| NAD+ | 4 | 97.85% | May 27, 2026 |
| TB-500 Thymosin Beta-4 | 3 | 97.64% | Jun 14, 2026 |
| TB-500 Fragment 17-23 | 2 | 93.8% | May 26, 2026 |
| CJC-1295 | 2 | 99.7% | Sep 8, 2026 |
| CJC-1295 DAC | 2 | n/a | Apr 22, 2026 |
| CJC-1295 No DAC | 2 | 90.22% | Feb 8, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| CJC-1295 | CP10/260403 | n/a | Lab E | Sep 8, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Sep 8, 2026 | verify |
| BPC-157 | n/a | 99.9% | Lab E | Sep 8, 2026 | verify |
| Retatrutide | Lot # 072266 MFG : 7/18/2026 | 99.8% | Lab G | Sep 7, 2026 | verify |
| Retatrutide | jul.2,2026 | 99.9% | Lab G | Sep 4, 2026 | verify |
| Melanotan II | n/a | 99.7% | Lab E | Sep 3, 2026 | verify |
| Retatrutide | RT20_25512747_060626 | 99.9% | Lab E | Sep 3, 2026 | verify |
| Tirzepatide | July 18.2026 | 99.9% | Lab E | Aug 25, 2026 | verify |
| Tesamorelin | n/a | 99.9% | Lab E | Aug 25, 2026 | verify |
| Retatrutide | n/a | 99.7% | Lab G | Aug 20, 2026 | verify |
| GHK-Cu | n/a | 99.7% | Lab G | Aug 20, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 2, 2026 | verify |
| MOTS-c | n/a | 99.3% | Lab E | Aug 2, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab G | Jul 29, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab G | Jul 29, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Jul 20, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Jul 20, 2026 | verify |
| Retatrutide | n/a | 99.7% | Lab E | Jul 19, 2026 | verify |
| Retatrutide | n/a | 99.2% | Lab E | Jul 19, 2026 | verify |
| MOTS-c | n/a | 98% | Lab E | Jul 13, 2026 | verify |
| Tesamorelin | n/a | 98.1% | Lab E | Jul 12, 2026 | verify |
| Tesamorelin | Apr.2,2026 | 99.5% | Lab E | Jul 12, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Jul 12, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jul 12, 2026 | verify |
| Retatrutide | n/a | n/a | Lab G | Jul 8, 2026 | verify |
Showing 25 most recent of 317. Search the full database on the CoA page.
Sell or represent LiliPeptide? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/lilipeptide/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/lilipeptide.svg" alt="LiliPeptide: lab tested, 317 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.